SPR Therapeutics Names Senior Vice President Of Research And Development

SPR Therapeutics LLC, a medical device company in Highland Hills that has developed a neurostimulation platform for chronic and acute pain, has promoted Joseph Boggs, Ph.D., to senior vice president of research and development.

Boggs “has led and made significant contributions to our R&D efforts, resulting in multiple patents and publications, FDA clearance of our SPRINT Peripheral Nerve Stimulation (PNS) System and significant non-dilutive federal grant and contract funding,” said Maria Bennett, SPR’s founder, president and CEO, in a news release.

The SPRINT system was designed to activate target nerve fibers, delivering pain relief without opioids, permanent implants or tissue destruction. In his role at SPR, Boggs will lead the R&D team to publish clinical data from future clinical trials in new pain indications, to advance the SPRINT system, and protect SPR’s inventions with new patents.

SPR said in its release that Boggs is currently serving a second term on the U.S. Department of Veterans Affairs Advisory Committee on Prosthetics and Special Disabilities Programs, reporting to the Secretary of the VA, where he “provides guidance on the research and development of rehabilitation technology, services and programs that serve Veterans with serious incapacities.”

Boggs received a bachelor’s degree in electrical engineering from the University of Virginia and earned his master’s and doctoral degrees in biomedical engineering from Case Western Reserve University.

This story originally appeared on Crain’s Cleveland Business.